While chronic IL-1 exposure renders the sublines resistant to IL-1- and TNFα-induced cytotoxicity, based on initial experiments (data not shown), we expect the LNas1 and LNbs1 sublines to remain responsive to growth factors and cytokines that support tumor progression, thereby conferring a growth advantage in the tumor microenvironment. The gene discussed is IL1A; the disease is neoplasm.